OIL.AX Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: October 20, 2025
Report Source: 2025 Annual Report
Optiscan Imaging Ltd. Stock Analysis OIL.AX
Optiscan Imaging Ltd. is engaged in the development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The company is headquartered in Melbourne, Victoria. The company creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. The company is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Read More Optiscan Imaging Ltd (OIL.AX) Chart
Key Statistics of Optiscan Imaging Ltd (OIL.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.11Volume
15.91KP/E Ratio (TTM)
-52 Week Range
Market Cap
117.47MAvg. Volume
134.09KDividend Yield
-Financial Metrics & Statements of Optiscan Imaging Ltd (OIL.AX)
FAQ's for Optiscan Imaging Ltd (OIL.AX)
- According to Musaffa’s Shariah screening methodology, Optiscan Imaging Ltd (OIL.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.